Generic Medicines Transition Tender

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("THE AUTHORITY")

Source
Find a Tender
Type
Framework (Supply)
Duration
21 month (est.)
Value
£2M
Sector
HEALTH
Published
20 May 2022
Delivery
01 May 2022 to 31 Jan 2024 (est.)
Deadline
n/a

Concepts

Location

Edinburgh

Geochart for 2 buyers and 18 suppliers

Description

This Procurement is for the supply of a range of Generic Medicines to health boards across NHS Scotland. The Goods have been split into 7 individual Framework Agreements. Full details of each individual Framework Agreement is contained in section II.2 of this notice.

Lot Division

1 NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol Inhaler

The Supply of Treprostinil Solution for Infusion to NHS Scotland in a range of presentations. The authority has not awarded the Beclometasone / Formoterol Inhaler. The authority has awarded each product line as a multi-supplier unranked framework agreement. Start Date: 01.05.22 End Date: 30.04.23

2 NP35922c - Pirfenidone Tablets

Supply of Pirfenidone Tablets in a range of presentations. The authority has awarded each line to a single Framework Participant within the single supplier Framework Agreement. Start Date: 01.05.22 End Date: 30.04.23

3 NP39722b - Sorafenib & Thalidomide Tablets

The Supply of Sorafenib & Thalidomide Tablets to NHS Scotland in a range of presentations. The authority has awarded each product line as a multi-supplier unranked framework agreement. Start Date: 01.05.22 End Date: 31.01.23

4 NP39722c - Sunitinib Tablets

Supply of Sunitinib Tablets in a range of presentations. The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement. Start Date: 01.05.22 End Date: 31.01.23

5 NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan Tablets

Supply of Deferasirox dispersible tablets, Sapropterin soluble tablets & Tolvaptan tablets in a range of presentations. The authority will not be awarding Hyoscine butylbromide tablets. The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement. Start Date: 01.05.22 End Date: 31.07.23

6 NP40922b - Oxycodone/Naloxone Tablets

The Supply of Oxycodone/Naloxone Tablets to NHS Scotland in a range of presentations. The authority has awarded each product line as a multi-supplier unranked framework agreement. Start Date: 01.05.22 End Date: 31.01.24

7 NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines

The supply of additional generic medicines used as Analgesics, Anaesthetics & to treat musculoskeletal conditions. This includes the supply of Co-Codamol, Ibuprofen & Paracetamol in a range of presentations. The authority has awarded each line to a single Framework Participant within this single supplier Framework Agreement. Start Date: 01.05.22 End Date: 31.01.24

Award Detail

1 Aop Orphan (Birmingham)
  • NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol Inhaler
  • Num offers: 2
  • Value: £24,986 [share]
  • Awarded to group of suppliers.
2 DR Reddys Laboratories (Beverley)
  • NP35922b - Treprostinil Solution for Infusion & Beclometasone / Formoterol Inhaler
  • Num offers: 2
  • Value: £24,986 [share]
  • Awarded to group of suppliers.
3 Accord (Devon)
  • NP35922c - Pirfenidone Tablets
  • Num offers: 5
  • Value: £236,982
4 Accord (Devon)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
5 Bayer (Reading)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
6 Bristol Myers Squibb Pharmaceuticals (London)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
7 Sandoz (Camberley)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
8 Teva (Castleford)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
9 Zentiva Pharma (London)
  • NP39722b - Sorafenib & Thalidomide Tablets
  • Num offers: 6
  • Value: £479,623 [share]
  • Awarded to group of suppliers.
10 Sandoz (Camberley)
  • NP39722c - Sunitinib Tablets
  • Num offers: 8
  • Value: £14,970
11 Napp Pharmaceuticals (Cambridge)
  • NP40922b - Oxycodone/Naloxone Tablets
  • Num offers: 2
  • Value: £5,853 [share]
  • Awarded to group of suppliers.
12 Zentiva Pharma (London)
  • NP40922b - Oxycodone/Naloxone Tablets
  • Num offers: 2
  • Value: £5,853 [share]
  • Awarded to group of suppliers.
13 Aguettant (Bristol)
  • NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines
  • Num offers: 4
  • Value: £153,119 [share]
  • Awarded to group of suppliers.
14 Bbraun Medical (Sheffield)
  • NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines
  • Num offers: 4
  • Value: £153,119 [share]
  • Awarded to group of suppliers.
15 Martindale Pharma (Romford)
  • NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines
  • Num offers: 4
  • Value: £153,119 [share]
  • Awarded to group of suppliers.
16 Piramal CC (West Drayton)
  • NP40922c - Analgesics, Anaesthetics & Musculoskeletal Generic Medicines
  • Num offers: 4
  • Value: £153,119 [share]
  • Awarded to group of suppliers.
17 Accord (Devon)
  • NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan Tablets
  • Num offers: 9
  • Value: £882,986 [share]
  • Awarded to group of suppliers.
18 Teva (Castleford)
  • NP39822b - Deferasirox dispersible tablets, Hyoscine butylbromide tablets, Sapropterin soluble tablets & Tolvaptan Tablets
  • Num offers: 9
  • Value: £882,986 [share]
  • Awarded to group of suppliers.

Award Criteria

Logistics 5.0
PRICE 95.0

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Award on basis of price.

Other Information

The estimated value(s) referred to in Section 11.1.7 & each lot cover(s) the contract duration for each individual Framework Agreement being awarded as a result of this procurement. (SC Ref:693776)

Reference

Domains